Published in Tumour Biol on January 01, 1996
Ovarian cancer pathogenesis: a model in evolution. J Oncol (2009) 1.77
Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res (2006) 1.52
Assay of mucins in human tear fluid. Exp Eye Res (2007) 1.44
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. J Ovarian Res (2009) 1.33
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer Lett (2006) 1.25
Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. J Proteome Res (2008) 1.21
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol Cancer (2014) 1.10
CA125 in ovarian cancer. Biomark Med (2007) 1.10
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers. Expert Opin Med Diagn (2009) 1.04
Phase II biomarker trial of a multimarker diagnostic for ovarian cancer. J Cancer Res Clin Oncol (2010) 1.04
Aberrant glycosylation as biomarker for cancer: focus on CD43. Biomed Res Int (2014) 0.97
A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One (2012) 0.95
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer (2004) 0.89
Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care. Cancer Prev Res (Phila) (2012) 0.88
Identification of an atypical zinc metalloproteinase, ZmpC, from an epidemic conjunctivitis-causing strain of Streptococcus pneumoniae. Microb Pathog (2012) 0.83
Deciphering the molecular nature of ovarian cancer biomarker CA125. Int J Mol Sci (2012) 0.82
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer. Yonsei Med J (2016) 0.78
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer. Int J Gynecol Cancer (2013) 0.77
Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer. Am J Nucl Med Mol Imaging (2016) 0.77
Epidemic Keratoconjunctivitis-Causing Adenoviruses Induce MUC16 Ectodomain Release To Infect Ocular Surface Epithelial Cells. mSphere (2016) 0.76
Development and characterization of three novel monoclonal antibodies against CA-125. Monoclon Antib Immunodiagn Immunother (2014) 0.75
The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A (1979) 5.33
THE STANDARDIZATION OF ANTIPNEUMOCOCCIC SERUM TYPES I AND II. J Exp Med (1930) 5.18
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
A developmental switch sufficient for flower initiation in diverse plants. Nature (1995) 4.70
One or more bound planets per Milky Way star from microlensing observations. Nature (2012) 4.68
Interactive memory systems in the human brain. Nature (2001) 4.53
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A (1998) 4.48
A mathematical evaluation of the core conductor model. Biophys J (1966) 4.41
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 4.25
Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet (1999) 4.24
High serum S100B levels for trauma patients without head injuries. Neurosurgery (2001) 4.16
Titration of antibodies to salmonella O antigens by enzyme-linked immunosorbent assay. Infect Immun (1972) 4.13
The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod (1989) 4.13
Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch Intern Med (1998) 4.07
Leukotrienes are potent constrictors of human bronchi. Nature (1980) 4.04
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol (2001) 3.94
Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron (2001) 3.92
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst (1996) 3.53
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Prostaglandins and thromboxanes. Annu Rev Biochem (1978) 3.47
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A (1981) 3.42
A genetic framework for floral patterning. Nature (1998) 3.42
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest (2001) 3.37
The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer (1995) 3.29
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol (1990) 3.21
EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT. Br J Ophthalmol (1962) 3.18
The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem (1997) 3.16
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol (2004) 3.03
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem (1991) 2.96
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes (1998) 2.94
A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem (1987) 2.94
P[Switch], a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci U S A (2001) 2.92
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90
Radiosurgery for venous angiomas. J Neurosurg (1993) 2.88
Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem (1997) 2.79
Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A (1980) 2.77
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A (1975) 2.75
Control of organ asymmetry in flowers of Antirrhinum. Cell (1999) 2.74
Antigen from colon of germfree rats and antibodies in human ulcerative colitis. Ann N Y Acad Sci (1965) 2.72
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature (1994) 2.53
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology (2001) 2.46
The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet (1996) 2.45
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol (1992) 2.43
Lead and hyperactivity. Lancet (1972) 2.42
Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J Neurophysiol (2004) 2.41
Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40
Health status in VA patients: results from the Veterans Health Study. Am J Med Qual (1999) 2.35
Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol (1983) 2.33
The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport. J Biol Chem (1992) 2.31
The extracellular potential field of the single active nerve fiber in a volume conductor. Biophys J (1968) 2.31
Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax (2004) 2.31
In vivo degradation of resin-dentin bonds in humans over 1 to 3 years. J Dent Res (2000) 2.30
Structure of leukotriene C. Identification of the amino acid part. Biochem Biophys Res Commun (1979) 2.30
Mid-Pleistocene Acheulean-like stone technology of the Bose basin, South China. Science (2000) 2.28
Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res (1998) 2.27
Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25
Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol (1982) 2.22
Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. Clin Exp Immunol (1973) 2.21
Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res (1991) 2.20
The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18
MRI findings in Susac's syndrome. Neurology (2003) 2.17
Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health (1993) 2.17
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J (1995) 2.14
BCG and cancer (first of two parts). N Engl J Med (1974) 2.13
PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer (1996) 2.13
Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (1984) 2.12
Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases. Clin Exp Immunol (1966) 2.11
Expression of a dominant allele of human ARF1 inhibits membrane traffic in vivo. J Cell Biol (1994) 2.11
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Prostaglandins. Annu Rev Biochem (1975) 2.09
Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. Cell Immunol (1974) 2.07
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol (2000) 2.04
Nursing: an intellectual activity. BMJ (1991) 2.03
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem (1997) 2.03
Immunological studies in ulcerative colitis. IV. Origin of autoantibodies. J Exp Med (1968) 2.02
Why nursing education has to change. Br Med J (Clin Res Ed) (1986) 2.01
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A (1999) 2.00
Inhibin as a marker for granulosa-cell tumors. N Engl J Med (1989) 1.97
Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol (2001) 1.96
[Multidisciplinary treatment of cerebral arteriovenous malformations: preliminary results in 115 consecutive patients]. Ned Tijdschr Geneeskd (1997) 1.96
Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol (1989) 1.95
Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem (1999) 1.94